Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Publication
, Journal Article
Riely, GJ; Wood, DE; Loo, BW; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Chang, JY; Chirieac, LR; DeCamp, M; Desai, A; Dilling, TJ; Ng, T ...
Published in: J Natl Compr Canc Netw
June 2025
Thymomas and thymic carcinomas are rare mediastinal tumors that originate in the thymus. Patients with thymoma may experience symptoms associated with autoimmune paraneoplastic diseases (such as myasthenia gravis), which typically do not occur in patients with thymic carcinoma. The NCCN Guidelines for Thymomas and Thymic Carcinomas provide guidance for the diagnosis, treatment, and surveillance of patients with thymoma and thymic carcinoma. Involvement of a multidisciplinary team with experience treating thymomas and thymic carcinomas is highly recommended.
Duke Scholars
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2025
Volume
23
Issue
6
Start / End Page
255 / 269
Location
United States
Related Subject Headings
- Thymus Neoplasms
- Thymoma
- Oncology & Carcinogenesis
- Myasthenia Gravis
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Riely, G. J., Wood, D. E., Loo, B. W., Aisner, D. L., Akerley, W., Bauman, J. R., … Hang, L. (2025). Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw, 23(6), 255–269. https://doi.org/10.6004/jnccn.2025.0027
Riely, Gregory J., Douglas E. Wood, Billy W. Loo, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, et al. “Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.” J Natl Compr Canc Netw 23, no. 6 (June 2025): 255–69. https://doi.org/10.6004/jnccn.2025.0027.
Riely GJ, Wood DE, Loo BW, Aisner DL, Akerley W, Bauman JR, et al. Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 Jun;23(6):255–69.
Riely, Gregory J., et al. “Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.” J Natl Compr Canc Netw, vol. 23, no. 6, June 2025, pp. 255–69. Pubmed, doi:10.6004/jnccn.2025.0027.
Riely GJ, Wood DE, Loo BW, Aisner DL, Akerley W, Bauman JR, Bharat A, Chang JY, Chirieac LR, DeCamp M, Desai A, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Lin J, Lovly CM, Maldonado F, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patel SP, Patil T, Polanco PM, Riess J, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory K, Hang L. Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 Jun;23(6):255–269.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2025
Volume
23
Issue
6
Start / End Page
255 / 269
Location
United States
Related Subject Headings
- Thymus Neoplasms
- Thymoma
- Oncology & Carcinogenesis
- Myasthenia Gravis
- Medical Oncology
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis